Ozgur Harmanci1, Taylan Kav, Bulent Sivri. 1. Department of Gastroenterology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey. ozgurmd@hacettepe.edu.tr
Abstract
BACKGROUND: Red cell distribution width (RDW) has been shown as a distinctive marker of mortality and morbidity in a wide spectrum of conditions related to systemic inflammation or deficiency of antioxidant nutrients. OBJECTIVE: We aimed to investigate the predictive value of RDW in detection of intestinal atrophy in celiac disease (CD). METHODS: Iron indices and RDW were studied in 49 patients with CD to evaluate the utilization of RDW as a predictive marker for presence of intestinal atrophy. RESULTS: Sixty-nine percent of patients had iron deficiency at initial presentation and 89% had abnormal RDW defined as >14. Receiver operating characteristics curves of RDW has been found to be a predictive of intestinal atrophy at levels higher than 17.25 (68% sensitivity and 85% specificity). In patients with transglutaminase antibody IgA titers >200 U/l, RDW level >17.75 showed 76% sensitivity and 100% specificity for intestinal atrophy. CONCLUSIONS: We suggest that RDW can be used as a surrogate marker of atrophy in patients with iron deficiency and suspected CD. In addition, the sensitivity, specificity, negative and positive predictive values of RDW increases when used in combination with high levels of transglutaminase IgA antibody.
BACKGROUND: Red cell distribution width (RDW) has been shown as a distinctive marker of mortality and morbidity in a wide spectrum of conditions related to systemic inflammation or deficiency of antioxidant nutrients. OBJECTIVE: We aimed to investigate the predictive value of RDW in detection of intestinal atrophy in celiac disease (CD). METHODS:Iron indices and RDW were studied in 49 patients with CD to evaluate the utilization of RDW as a predictive marker for presence of intestinal atrophy. RESULTS: Sixty-nine percent of patients had iron deficiency at initial presentation and 89% had abnormal RDW defined as >14. Receiver operating characteristics curves of RDW has been found to be a predictive of intestinal atrophy at levels higher than 17.25 (68% sensitivity and 85% specificity). In patients with transglutaminase antibody IgA titers >200 U/l, RDW level >17.75 showed 76% sensitivity and 100% specificity for intestinal atrophy. CONCLUSIONS: We suggest that RDW can be used as a surrogate marker of atrophy in patients with iron deficiency and suspected CD. In addition, the sensitivity, specificity, negative and positive predictive values of RDW increases when used in combination with high levels of transglutaminase IgA antibody.
Authors: T A Kemppainen; V M Kosma; E K Janatuinen; R J Julkunen; P H Pikkarainen; M I Uusitupa Journal: Am J Clin Nutr Date: 1998-03 Impact factor: 7.045
Authors: Andrew D Hopper; Simon S Cross; David P Hurlstone; Mark E McAlindon; Alan J Lobo; Marios Hadjivassiliou; Marion E Sloan; Simon Dixon; David S Sanders Journal: BMJ Date: 2007-03-23
Authors: Domingo A Pascual-Figal; Juan C Bonaque; Belen Redondo; Cesar Caro; Sergio Manzano-Fernandez; Jesús Sánchez-Mas; Iris P Garrido; Mariano Valdes Journal: Eur J Heart Fail Date: 2009-09 Impact factor: 15.534
Authors: Ingrid Dahlbom; Ilma R Korponay-Szabó; Judit B Kovács; Zsuzsanna Szalai; Markku Mäki; Tony Hansson Journal: J Pediatr Gastroenterol Nutr Date: 2010-02 Impact factor: 2.839
Authors: Matthew R Donaldson; Sean D Firth; Holly Wimpee; Kristin M Leiferman; John J Zone; Wyatt Horsley; Molly A O'Gorman; W Daniel Jackson; Susan L Neuhausen; Christopher M Hull; Linda S Book Journal: Clin Gastroenterol Hepatol Date: 2007-04-11 Impact factor: 11.382
Authors: Daniel Vasile Balaban; Alina Popp; Andrei Marian Lungu; Raluca Simona Costache; Ioana Alina Anca; Mariana Jinga Journal: Medicine (Baltimore) Date: 2015-04 Impact factor: 1.889